Inflammatory gradient in Barrett's oesophagus: implications for disease complications. - Wikidata - awgldk - TriplyDB

Inflammatory gradient in Barrett's oesophagus: implications for disease complications.

Inflammatory gradient in Barrett's oesophagus: implications for disease complications.

http://www.wikidata.org/entity/Q35594952

about

Comparative Multi-Epitope-Ligand-Cartography reveals essential immunological alterations in Barrett's metaplasia and esophageal adenocarcinoma Genetic susceptibility to Barrett's oesophagus: Lessons from early studies Esophageal Cancer: Insights From Mouse Models Genetic Biomarkers of Barrett's Esophagus Susceptibility and Progression to Dysplasia and Cancer: A Systematic Review and Meta-Analysis The promise of PD-1 inhibitors in gastro-esophageal cancers: microsatellite instability vs. PD-L1 The tumor microenvironment in esophageal cancer The evidence base of proton pump inhibitor chemopreventative agents in Barrett's esophagus--the good, the bad, and the flawed!Shape of Barrett's epithelium is associated with prevalence of erosive esophagitis.Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis.Pathophysiology and treatment of Barrett's esophagus.The immune cell composition in Barrett's metaplastic tissue resembles that in normal duodenal tissue.The definition and management of Barrett's oesophagus: a case report, review of the literature and a suggestion for the future.Cancer-related inflammation and Barrett's carcinogenesis: interleukin-6 and STAT3 mediate apoptotic resistance in transformed Barrett's cells.Expression of CXC receptor 1 and 2 in esophageal mucosa of patients with reflux esophagitis Squamous tissue lymphocytes in the esophagus of controls and patients with reflux esophagitis and Barrett's esophagus are characterized by a non-inflammatory phenotype.Effect of lycopene against gastroesophageal reflux disease in experimental animals The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia.Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation?Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma.Impact of endoscopically minimal involvement on IL-8 mRNA expression in esophageal mucosa of patients with non-erosive reflux disease.Targeting chemokine pathways in esophageal adenocarcinoma.Barrett esophagus: what a mouse model can teach us about human disease Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma.Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma Spatial predisposition of dysplasia in Barrett's esophagus segments: a pooled analysis of the SURF and AIM dysplasia trials Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis.Esophageal adenocarcinoma arising in Barrett esophagus NOD-Like Receptor Protein 3 Inflammasome Priming and Activation in Barrett's Epithelial Cells Circulating inflammatory cytokines and adipokines are associated with increased risk of Barrett's esophagus: a case-control study IL33 Is a Stomach Alarmin That Initiates a Skewed Th2 Response to Injury and Infection.Cdx genes, inflammation, and the pathogenesis of intestinal metaplasia.Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia.Molecular mechanisms of Barrett's esophagus.Role of acid suppression in the development and progression of dysplasia in patients with Barrett's esophagus.Could signal transducer and activator of transcription 3 be a therapeutic target in obesity-related gastrointestinal malignancy?The role of glycogen synthase kinase 3-β in immunity and cell cycle: implications in esophageal cancer.The role of inflammation in cancer of the esophagus.A clinical perspective on the role of chronic inflammation in gastrointestinal cancer.Gallstones, cholecystectomy, and risk of digestive system cancers.

P2860

Q21245711-4C9588F4-A38E-42AE-A596-FF61023AAA32 Q26740556-B8092C04-058B-4FEA-95A7-4ADDAC467F24 Q26783904-81AD8055-2C4F-4376-B873-6077CA4D3F19 Q26786469-CBF18F1F-E094-4A46-9AA5-9F84F6358639 Q28069924-A1512F45-2A75-496D-A237-B8B4B464160A Q28077074-57368B8E-0B55-4F5F-9763-46898E482FE6 Q28218616-9FA1D365-F347-409C-8DB7-EDB82A221683 Q33612247-0865F6CD-D712-481E-84D0-2AEF22317418 Q33840598-F634BDCB-FCEC-44D4-AD2E-E5CFDE33D10E Q34063695-55D41744-405D-4F2E-9625-D1BFB225E827 Q34235047-01646BE4-BAC8-4851-8F2E-267B44213305 Q34534670-ADAC32B2-6040-4F75-9A82-E39DD161C2E7 Q34718996-96AC76B8-DD4C-4B17-8470-AEAD6DD08A8B Q35011084-1BF4D565-DFCB-4E4C-9431-19016280185F Q35234836-01835686-71D0-4A9B-9101-73891D26AC94 Q35608480-C7EF89F1-8D6C-42A9-A40A-AC189CA3DFF9 Q36041651-FBF65BB7-C99A-4C46-B38E-E58DB769B832 Q36041656-7B1B2D0D-1219-48B0-9E17-FD0EDC8B824B Q36132761-C0BB2CD1-4ED8-417A-8E8C-A1538D65EF29 Q36180555-95A43909-2BD7-4DBD-8E76-733EBE5F137C Q36187424-3DC2442B-AF6E-4915-A23D-6DF19AA68328 Q36556299-BF53B2F0-872C-4FCB-88BB-CA13FC1B9B04 Q36570868-CEEA7BF6-115B-4D6B-A304-9959B549AEDC Q36649565-6F0BCAAA-3DFC-4606-BBAC-033AEC1E57C7 Q36662322-CCC37E6D-416B-40E7-A2B4-D53231D5555B Q36672689-794BE32A-B889-4BFB-8CF5-FC1E65A5EE50 Q36832496-1CADF0A5-8C29-4ABC-B746-1A311C6374E6 Q37169303-3D83C7D8-9FE3-430D-96BF-B5ABA6F8C6F0 Q37297049-2FA6E7AE-8101-47C7-9CDF-E7AC277CE8D8 Q37505223-21B9BC6B-990A-406A-9CB0-392D272C5B9C Q37634925-4768453D-F860-4DB0-A7A2-CB1B7F577057 Q37809363-6D4AB9D1-47A4-42E4-9E93-1FB0848B96AE Q37880176-4FDB18CA-8FE5-475F-9D1B-B3C4E71EF5FA Q37943774-89433852-8346-4058-93E1-DC58C80560DB Q37957710-3B5C66BE-8522-4810-8219-19FB7F47541B Q38155819-9E54C6DD-A68F-48C9-B6A6-268E5DC59769 Q38166249-243BCE3C-967F-40C1-8571-1B52B048587C Q38214324-5704EB4F-C69E-478F-B043-AF80D8B82120 Q38241837-159CDD1A-12A7-48E8-93DF-2E7815542F9F Q38422523-877CFF66-DB14-4036-80ED-9C60DAC8C84B

P2860

Inflammatory gradient in Barrett's oesophagus: implications for disease complications.

http://www.wikidata.org/entity/Q35594952

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Inflammatory gradient in Barrett's oesophagus: implications for disease complications.

@ast

Inflammatory gradient in Barrett's oesophagus: implications for disease complications.

@en

type

label

Inflammatory gradient in Barrett's oesophagus: implications for disease complications.

@ast

Inflammatory gradient in Barrett's oesophagus: implications for disease complications.

@en

prefLabel

Inflammatory gradient in Barrett's oesophagus: implications for disease complications.

@ast

Inflammatory gradient in Barrett's oesophagus: implications for disease complications.

@en

P1433

Q35594952-4D9C618D-9ADB-41AC-A144-D79B080755E8

P1476

Q35594952-741D39A5-20E6-46CD-B87B-1237843420E3

P2093

Q35594952-058E0177-6436-48FE-BEA2-8A9FC279DEEB

Q35594952-635E264A-9CCE-4511-B7D4-B638DD14869B

Q35594952-696467AD-8827-4CA9-B0A5-FB25E70002A4

Q35594952-6A0216BB-BDEC-4DD9-BFB7-86A5585B9F65

Q35594952-8D398A8B-E4AA-4795-9BEA-D070245792A7

Q35594952-962196A8-2BCB-4CE8-8F3A-9373F5170ADA

Q35594952-9822A9D1-B133-4617-A63D-D210CEDC1575

P2860

Q35594952-0B92E43B-71F2-4DE3-9977-81B03D6EF43D

Q35594952-1F4070C8-57DF-4B0A-92F7-90D8192150C4

Q35594952-22E22EC8-4BB3-4ED7-A0ED-74FA968FC925

Q35594952-29B26BFF-B946-4DE0-B8BF-97B985F552AF

Q35594952-2CDA337C-B32D-41BE-82F0-D4F5E28A924B

Q35594952-309666E2-60FC-4808-B9BA-41494F45DF55

Q35594952-310E8C1B-F2BF-471C-B19C-FC0A0D86849A

Q35594952-355CF4C9-607F-4888-8DD5-B87AA5374BE6

Q35594952-3D2067A5-E7FE-4638-8DC9-AB2C3B9F85FF

Q35594952-45812DA7-1B14-4AC5-83C9-48D78D23DFC2

P304

Q35594952-20212434-2AB9-463A-9B1A-AF5FB47F7D84

P31

Q35594952-03F5FF21-67CE-4D26-82E7-2730A8B2E885

P356

Q35594952-1BB536C3-5135-43B6-AF93-71DEC98B42FD

P407

Q35594952-37ADBF7C-145B-4603-8D3C-45C9EA4E0A43

P433

Q35594952-66988B9E-B6D4-4D4C-BBB0-8D4A8EE99146

P478

Q35594952-CDE0AD1B-C995-4C0D-8B62-DF116C66E445

P577

Q35594952-1C778AF1-AE81-4892-B7D5-06891965625A

P5875

Q35594952-9B0146D3-B91D-4FAE-8761-3483F50C745D

P698

Q35594952-4BEDCE22-3936-4566-9CBB-7D8046160E99

P921

Q35594952-E4CD4AE5-107F-4C6C-8965-CF946B8CFB0F

P932

Q35594952-EE63BC67-1FE1-4F55-935C-0EA0A51C7DCC

P356

P1433

P1476

Inflammatory gradient in Barrett's oesophagus: implications for disease complications.

@en

P2093

B A Onwuegbusi

http://www.w3.org/2001/XMLSchema#string

I T Saeed

http://www.w3.org/2001/XMLSchema#string

M J G Farthing

http://www.w3.org/2001/XMLSchema#string

P Sirieix

http://www.w3.org/2001/XMLSchema#string

R C Fitzgerald

http://www.w3.org/2001/XMLSchema#string

S Abdalla

http://www.w3.org/2001/XMLSchema#string

W R Burnham

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

Is there publication bias in the reporting of cancer risk in Barrett's esophagus?

Cancer statistics, 1998.

A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity.

A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion.

The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett.

Alkaline gastro-oesophageal reflux: dual probe pH monitoring.

Inflammation of the gastro-oesophageal junction (carditis) in patients with symptomatic gastro-oesophageal reflux disease: a prospective study

Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants

Immune stimulatory potential of B7.1 and B7.2 retrovirally transduced melanoma cells: suppression by interleukin 10.

P304

316-322

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.51.3.316

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2002-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275007540

http://www.w3.org/2001/XMLSchema#string

P698

12171950

http://www.w3.org/2001/XMLSchema#string

P921

P932

1773354

http://www.w3.org/2001/XMLSchema#string